Company Overview

Detailed company information

Basic Information

Ticker: MXCT

Country: US

Headquarter: Rockville, MD

Employees: 91

Financial Information

Market Cap: $138.2 Million

Currency: USD

Sector: Healthcare

Industry: Biotechnology

Stock Price Chart

Stock Data provided by Financial Modeling Prep

About MaxCyte, Inc.

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.

Last Updated: Sep 2026

Here's what you can ask

Earnings Transcripts

Latest

Earnings Transcript for 2026 - Q2Released: Aug 12, 2026

Earnings Transcript for 2026 - Q1Released: May 12, 2026

Earnings Transcript for 2025 - Q4Released: Mar 24, 2026

Earnings Transcript for 2025 - Q3Released: Nov 12, 2025

Earnings Transcript for 2025 - Q2Released: Aug 07, 2025

Earnings Transcript for 2025 - Q1Released: May 10, 2025

Earnings Transcript for 2024 - Q4Released: Mar 11, 2025

Earnings Transcript for 2024 - Q3Released: Nov 06, 2024

Earnings Transcript for 2024 - Q2Released: Aug 07, 2024

Earnings Transcript for 2024 - Q1Released: May 11, 2024

Earnings Transcript for 2023 - Q4Released: Mar 12, 2024

Earnings Transcript for 2023 - Q3Released: Nov 08, 2023

Earnings Transcript for 2023 - Q2Released: Aug 09, 2023

Earnings Transcript for 2023 - Q1Released: May 12, 2023

Earnings Transcript for 2022 - Q4Released: Mar 15, 2023

Earnings Transcript for 2022 - Q3Released: Nov 12, 2022

Earnings Transcript for 2022 - Q2Released: Aug 10, 2022

Earnings Transcript for 2022 - Q1Released: May 09, 2022

Earnings Transcript for 2021 - Q4Released: Mar 22, 2022

Earnings Transcript for 2021 - Q3Released: Nov 13, 2021

Earnings Transcript for 2021 - Q2Released: Sep 13, 2021